☆ 4.5 Article

N4BP3 promotes angiogenesis in hepatocellular carcinoma by binding with KAT2B

CANCER SCIENCE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Gastroenterology & Hepatology

Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases

Marina Serper et al.

Summary: HCC is a major cause of mortality in patients with advanced liver disease and is associated with significant morbidity. The evaluation of patient-reported outcomes (PROs) in HCC is lacking in systematic assessment. A review of studies found that poor PROs were associated with worse prognosis in HCC patients, although some patients had better PROs compared to those with cirrhosis. Treatment methods were found to have an impact on symptom burden, but further research is needed for more specific effects.

HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma

Ann-Lii Cheng et al.

Summary: The study demonstrated that atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients led to improved survival outcomes. After updated analysis, atezolizumab plus bevacizumab maintained its position as the first-line treatment option for advanced hepatocellular carcinoma.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Editorial Material Oncology

Nivolumab and sorafenib in hepatocellular carcinoma: lessons from the CheckMate 459 study Comment

Maria Reig et al.

LANCET ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death globally. Traditional treatments involve specific drugs, but the emergence of immune checkpoint inhibitors has revolutionized the management of HCC.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Recent advances in systemic therapy for hepatocellular carcinoma

Huajun Zhang et al.

Summary: Hepatocellular carcinoma (HCC) is a common and lethal malignancy worldwide. While therapeutic options for advanced HCC are limited, sorafenib has been the only proven effective systemic drug for more than a decade. However, the rapid progress of molecular targeted therapies in the past three years has significantly changed the treatment landscape for advanced HCC. The incorporation of immune checkpoint therapies and their combination with molecular targeted therapy are emerging tools to enhance the immune response.

BIOMARKER RESEARCH (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Signal transducer and activator of transcription 3 signaling in tumor immune evasion

Luying Zhang et al.

Summary: The underlying mechanism of tumor immune evasion, particularly the role of STAT3 in promoting tumor cell escape from immune surveillance through regulating autophagy molecules, immune factors, and immunosuppressive cell recruitment, is discussed in this review. The article also highlights the significance of the research on STAT3 signaling and tumor immune evasion in the development of targeted drugs for immunotherapy.

PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Review Oncology

Repurposing of drugs as STAT3 inhibitors for cancer therapy

Pathum S. Thilakasiri et al.

Summary: Drug repurposing is a valuable approach for rapidly introducing new cancer therapies into clinical practice. STAT3 inhibitors play a significant role in cancer treatment, but challenges remain in understanding the mechanisms of STAT3 activation and developing strategies to suppress its activity with various pharmaceutical agents.

SEMINARS IN CANCER BIOLOGY (2021)

添加到收藏夹

Article Microbiology

N4BP3 Regulates RIG-I-Like Receptor Antiviral Signaling Positively by Targeting Mitochondrial Antiviral Signaling Protein

Chen Wang et al.

Summary: N4BP3 is a positive regulator of the RLR signaling pathway by targeting MAVS, promoting virus-induced activation of IFN-β and ISRE, accelerating the interaction between MAVS and TRAF2, facilitating the ubiquitination modification of MAVS, and playing a critical role in RLR-mediated innate immune responses.

FRONTIERS IN MICROBIOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Systemic treatment of HCC in special populations

Lorenza Rimassa et al.

Summary: Recent years have witnessed significant progress in the systemic treatment of hepatocellular carcinoma (HCC), but there is a lack of high-quality evidence for patients with various comorbidities. Future clinical trials should be designed to specifically include patients with comorbidities to improve the safety and efficacy of HCC treatment in these subgroups.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Evolution of systemic treatment for advanced hepatocellular carcinoma

Tsung-Che Wu et al.

Summary: Over the past 20 years, systemic therapy for advanced hepatocellular carcinoma has evolved from traditional chemotherapy to molecular targeted therapy and immunotherapy targeting tumor angiogenesis or tumor immunity. The recent combination therapy of atezolizumab and bevacizumab has shown improved efficacy in treating advanced HCC without significant toxicities or negative impact on quality of life.

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity

Ruo-Yu Chen et al.

CELL DEATH AND DIFFERENTIATION (2020)

添加到收藏夹

Article Oncology

Functional Genomics Identifies Hepatitis-Induced STAT3-TYRO3-STAT3 Signaling as a Potential Therapeutic Target of Hepatoma

Chia-Liang Tsai et al.

CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Molecular therapies for HCC: Looking outside the box

Sandrine Faivre et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma

Ann-Lii Cheng et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeting STAT3 in Cancer Immunotherapy

Sailan Zou et al.

MOLECULAR CANCER (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeted therapy for hepatocellular carcinoma

Ao Huang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Review Immunology

Targeting Interleukin-6 Signaling in Clinic

Sujin Kang et al.

IMMUNITY (2019)

添加到收藏夹

Article Oncology

Two predictive precision medicine tools for hepatocellular carcinoma

Zhiqiao Zhang et al.

CANCER CELL INTERNATIONAL (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

JAK1-mediated Sirt1 phosphorylation functions as a negative feedback of the JAK1-STAT3 pathway

Wenhui Wang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

添加到收藏夹

Review Oncology

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Daniel E. Johnson et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

添加到收藏夹

Article Genetics & Heredity

The correlation analysis of miRNAs and target genes in metastasis of cervical squamous cell carcinoma

Jing Zhou et al.

EPIGENOMICS (2018)

添加到收藏夹

Review Oncology

The JAK/STAT3 axis: A comprehensive drug target for solid malignancies

Jennifer Huynh et al.

SEMINARS IN CANCER BIOLOGY (2017)

添加到收藏夹

Article Developmental Biology

The Nedd4 binding protein 3 is required for anterior neural development in Xenopus laevis

Lena-Maria Kiem et al.

DEVELOPMENTAL BIOLOGY (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Targeting transcription factor STAT3 for cancer prevention and therapy

Edna Zhi Pei Chai et al.

PHARMACOLOGY & THERAPEUTICS (2016)

添加到收藏夹

Article Oncology

Cbx4 Governs HIF-1α to Potentiate Angiogenesis of Hepatocellular Carcinoma by Its SUMO E3 Ligase Activity

Jie Li et al.

CANCER CELL (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Critical Role for Lysine 685 in Gene Expression Mediated by Transcription Factor Unphosphorylated STAT3

Maupali Dasgupta et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

DECADE IN REVIEW-HEPATOCELLULAR CARCINOMA HCC-subtypes, stratification and sorafenib

Gregory J. Gores

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

添加到收藏夹

Review Oncology

Revisiting STAT3 signalling in cancer: new and unexpected biological functions

Hua Yu et al.

NATURE REVIEWS CANCER (2014)

添加到收藏夹

Article Developmental Biology

The Nedd4-binding protein 3 (N4BP3) is crucial for axonal and dendritic branching in developing neurons

Michael J. Schmeisser et al.

NEURAL DEVELOPMENT (2013)

添加到收藏夹

Article Oncology

Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies

Pasquale Sansone et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

添加到收藏夹

Review Immunology

Suppressors of cytokine signaling and immunity

M Kubo et al.

NATURE IMMUNOLOGY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.